PNC Financial Services Group’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $56.1K | Buy |
2,638
+2,018
| +325% | +$42.9K | ﹤0.01% | 3045 |
|
|
2025
Q1 | $12K | Buy |
620
+100
| +19% | +$1.93K | ﹤0.01% | 3762 |
|
|
2024
Q4 | $9.28K | Buy |
520
+50
| +11% | +$892 | ﹤0.01% | 3829 |
|
|
2024
Q3 | $10.3K | Buy |
470
+425
| +944% | +$9.31K | ﹤0.01% | 3789 |
|
|
2024
Q2 | $351 | Buy |
+45
| New | +$351 | ﹤0.01% | 4583 |
|
|
2021
Q4 | – | Sell |
-2,000
| Closed | -$10K | – | 4600 |
|
|
2021
Q3 | $10K | Buy |
2,000
+1,000
| +100% | +$5K | ﹤0.01% | 3758 |
|
|
2021
Q2 | $7K | Buy |
+1,000
| New | +$7K | ﹤0.01% | 3803 |
|